Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiation. Found 16 abstracts

Mishra OP, Popov AV, Pietrofesa RA, Hwang WT, Andrake M, Nakamaru-Ogiso E, Christofidou-Solomidou M. Radiation activates myeloperoxidase (MPO) to generate active chlorine species (ACS) via a dephosphorylation mechanism - inhibitory effect of LGM2605. Biochimica et biophysica acta General subjects. 2020 Feb 05;:129548.
Bevelacqua JJ, Welsh J, Mortazavi S. Comments on "New concerns for neurocognitive function during deep space exposures to chronic, low dose rate, neutron radiation". eNeuro. 2019 Dec 17;.
Dong Y, Ridge JA, Ebersole B, Li T, Lango MN, Churilla TM, Donocoff K, Bauman JR, Galloway TJ. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral Oncol. 2019 Aug;95:59-64.
Kim AH, Konety B, Chen Z, Schumacher F, Kutikov A, Smaldone M, Abouassaly R, Khanna A, Kim SP. Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. Urology. 2018 Oct;120:173-9.
Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: A review of the literature and update on management options. Gynecol Oncol. 2018 Dec;151(3):562-72.   PMCID: Review
Chera B, Wang K, Monroe A, Galloway T, Amdur R, Hayes DN, Zevallos J, Mendenhall WM. Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?. Oral Oncol. 2017 Feb;65:125-6.
Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR. Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis. Breast Cancer Res Treat. 2017 Dec;166(3):787-91.
Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR, Galloway TJ. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer. Oral Oncol. 2017 Aug;71:122-8.
Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Radiother Oncol. 2016 Nov;121(2):294-8.
Porpiglia AS, Reddy SS, Farma JM. Retroperitoneal Sarcomas. Surg Clin North Am. 2016 Oct;96(5):993-1001.
Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncol. 2015 Nov;51(11):1034-40.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience. Am J Surg. 2014 Aug;208(2):254-9.
Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE, Elect Brachytherapy Working Grp. AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY (ASTRO) EMERGING TECHNOLOGY COMMITTEE REPORT ON ELECTRONIC BRACHYTHERAPY. International Journal of Radiation Oncology Biology Physics. 2010 Mar;76(4):963-72.   PMCID: not NIH funded
Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiotherapy and Oncology. 2010 Jul;96(1):6-12.   PMCID: Not required
Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH-RISK PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2009 Jun;74(2):383-7.   PMCID: PMC2905150
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiation

Radiation Prostate cancer Chemotherapy Hpv Hnc Chemoradiation Surgery THERAPY duration distant metastases Angiosarcoma Neurocognitive function Dose escalation local-control Cosmesis androgen randomized controlled-trial Leiomyosarcoma irradiation IMRT 045 has patents No US 10-951 B2-No US 10-030-040 B2-and No US 9-987-321 B2 US2008 Survivorship DEPRIVATION T4 issued and patents No PCT Combined Modality Therapy RADICAL Head and Neck Neoplasms Male grants from the National Institutes of Health (NIH) and the National Aeronautics Chemothearpy Female US17 rates Rheumatoid arthritis No PCT 049780 NEOADJUVANT intensity-modulated radiotherapy Kaplan-Meier Estimate TRIAL Space oncology stage breast-cancer tumor-control and has a founders equity position in LignaMed 006694 pending-LLC Morcellation oncology guidelines CLINICAL TARGET VOLUME phase-iii trial boost PCT AVP MCS-and MA report grants from the NIH during the conduct of the study RAP competing risk Adult Systemic therapy interoperative Targeted therapy fractionation Toxicity Middle Aged Pelvic lymph nodes Oropharynx 80 and over Aged Uterine sarcoma Retroperitoneal liposarcoma radiation-therapy intraoperative radiotherapy iort Breast Neoplasms IRRADIATION mortality Lgm2605 defining biochemical failure Cranial nerve palsy Prostatectomy Secoisolariciresinol diglucoside Young Adult Hemangiosarcoma High grade terminology alpha Time factor US2016 Oropharynx cancer Long-term follow-up p16 Neutrons Electronic Brachytherapy Hypochlorite ion hypofractionation Radiotherapy conformal radiation-therapy clinically localized adenocarcinoma escalation trial Head and neck cancer Long-term toxicity Breast cancer Target volume Quality of life Sbrt Prognosis Let Survival and No 35960 beta ratio ENO W-TH-and OM have nothing to disclose Hze carcinoma Prostate-specific antigen EXTERNAL-BEAM RADIOTHERAPY LYMPHADENECTOMY radiotherapy Active chlorine species diagnosis MCS and Space Administration (NASA) during the conduct of the study In addition energy x-rays Myeloperoxidase protraction PROSTATECTOMY ANDROGEN SUPPRESSION Retroperitoneal sarcoma suppression Growth rate Hypofractionated Aged 10-Year survivorship device drug therapy
Last updated on Monday, August 03, 2020